{
    "1617507442203443204": {
        "author_id": "5383942",
        "created_at": "2023-01-23T13:00:00.000Z",
        "edit_history_tweet_ids": [
            "1617507442203443204"
        ],
        "entities": {
            "annotations": [
                {
                    "end": 33,
                    "normalized_text": "Antigen Presenting System",
                    "probability": 0.581,
                    "start": 9,
                    "type": "Other"
                },
                {
                    "end": 51,
                    "normalized_text": "MAPS",
                    "probability": 0.6221,
                    "start": 48,
                    "type": "Other"
                }
            ],
            "hashtags": [
                {
                    "end": 198,
                    "start": 181,
                    "tag": "BehindTheScience"
                }
            ],
            "urls": [
                {
                    "display_url": "gsk.to/3XH8Vrp",
                    "end": 223,
                    "expanded_url": "https://gsk.to/3XH8Vrp",
                    "start": 200,
                    "status": 200,
                    "unwound_url": "https://www.gsk.com/en-gb/behind-the-science-magazine/maps-technology-new-age-vaccine-development-infectious-diseases/?linkId=100000179694775",
                    "url": "https://t.co/siK1XNpclx"
                }
            ]
        },
        "id": "1617507442203443204",
        "lang": "en",
        "public_metrics": {
            "bookmark_count": 1,
            "impression_count": 3958,
            "like_count": 19,
            "quote_count": 0,
            "reply_count": 9,
            "retweet_count": 4
        },
        "text": "Multiple Antigen Presenting System \u2013 also named MAPS \u2013 is a new vaccine technology with the potential to deliver breakthrough innovation \u2013 and the beauty of it is its simplicity. \n\n#BehindTheScience  https://t.co/siK1XNpclx"
    }
}